EM
CHRS icon

ELCO Management’s Coherus Oncology CHRS Stock Holding History

ELCO Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,716
Closed -$22K – 168
2024
Q2 		$22K Sell
12,716
-7,764
-38% -$15.6K 0.01% 154
2024
Q1 		$48.9K Buy
20,480
+5,286
+35% +$13K 0.03% 151
2023
Q4 		$50.6K Hold
15,194
– – 0.03% 139
2023
Q3 		$56.8K Buy
+15,194
New +$70.2K 0.04% 131

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ELCO Management's CHRS Position: Q3 2024 in Review

ELCO Management sold out of Coherus Oncology (CHRS) in Q3 2024, closing a stake of 12,716 shares — an estimated $22K sold.

ELCO Management first reported a position in CHRS in Q3 2023 and held it in 4 quarters. The position peaked at $56.8K in Q3 2023. 128 funds tracked by Wall St. Rank hold CHRS as of Q3 2024.

  • ELCO Management reported no remaining Coherus Oncology position as of Q3 2024 after selling out during the quarter.
  • ELCO Management sold 12,716 Coherus Oncology shares in Q3 2024, an estimated $22K.
  • ELCO Management first reported a position in Coherus Oncology in Q3 2023 and held it in 4 quarters.
  • ELCO Management's Coherus Oncology position peaked at $56.8K in Q3 2023.
  • 128 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2024.

Based on ELCO Management's 13F filing for Q3 2024, filed 14 Nov 2024.